GMAB — GENMAB A/S

Ownership history in Squarepoint Ops LLC  ·  13 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in GENMAB A/S (GMAB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2022 Q3)
Avg. % of fund
0.0%
First filed
2020 Q4
Last filed
2025 Q3
Quarters held
13
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 9,480 -84,753 -89.9% 0.00% $291K $30.67
2025 Q2 ADDED 94,233 +81,434 +636.3% 0.00% $1.9M $20.66
2025 Q1 REDUCED 12,799 -104,708 -89.1% 0.00% $251K $19.58
2024 Q4 ADDED 117,507 +108,705 +1235.0% 0.00% $2.5M $20.87
9 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    GMAB price (monthly, adj. close)

Other funds also holding GMAB

As of 2025 Q4 — sorted by position size

Paradigm Biocapital Advisors LP 3Y 5.53% Orbis Allan Gray Ltd 3Y 7Y 1.86% AIMZ Investment Advisors, LLC 3Y 7Y 1.44% Private Wealth Advisors, LLC 3Y 1.3% Terra Nova Asset Management LLC 3Y 7Y 1.23% HARDING LOEVNER LP 3Y 7Y 0.91% Avidity Partners Management LP 3Y 0.82% SUPERSTRING CAPITAL MANAGEMENT LP 0.48% VIRTUS ADVISERS, LLC 3Y 7Y 0.4% Perpetual Ltd 3Y 7Y 0.37%
← Back to Squarepoint Ops LLC Holdings